ID: ALA4642640

Max Phase: Preclinical

Molecular Formula: C22H25N5O2

Molecular Weight: 391.48

Molecule Type: Unknown

Representations

Canonical SMILES:  O=C(CNC(=O)N1CCN(Cc2ccccc2)CC1)NC1=CC2=CC=N[C@@H]2C=C1

Standard InChI:  InChI=1S/C22H25N5O2/c28-21(25-19-6-7-20-18(14-19)8-9-23-20)15-24-22(29)27-12-10-26(11-13-27)16-17-4-2-1-3-5-17/h1-9,14,20H,10-13,15-16H2,(H,24,29)(H,25,28)/t20-/m1/s1

Standard InChI Key:  DDAJILKCXCARLN-HXUWFJFHSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 391.48

Molecular Weight (Monoisotopic): 391.2008

AlogP: 1.46

#Rotatable Bonds: 5

Polar Surface Area: 77.04

Molecular Species: NEUTRAL

HBA: 4

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 7

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 13.27

CX Basic pKa: 6.99

CX LogP: -0.08

CX LogD: -0.22

Aromatic Rings: 1

Heavy Atoms: 29

QED Weighted: 0.80

Np Likeness Score: -0.94

References

1. Rana D, Kalamuddin M, Sundriyal S, Jaiswal V, Sharma G, Das Sarma K, Sijwali PS, Mohmmed A, Malhotra P, Mahindroo N..  (2020)  Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity.,  28  (1): [PMID:31744777] [10.1016/j.bmc.2019.115155]

Source

Source(1):

• Scientific Literature